Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion

Virology

Volumn 413, Issue 1, 2011, Pages 118-127

  Butrapet, Siritorn ^a   Childers, Thomas ^a   Moss, Kelley J ^a   Erb, Steven M ^b   Luy, Betty E ^a   Calvert, Amanda E ^a   Blair, Carol D ^b   Roehrig, John T ^a   Huang, Claire Y H ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Dengue virus; Envelope protein; Flavivirus; Fusion; Hinge; Mutagenesis

Indexed keywords

VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS 2; HINGE REGION; HUMAN; HUMAN CELL; INSECT CELL; MAMMAL CELL; MOSQUITO; NONHUMAN; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS REPLICATION;

AEDES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; DENGUE; DENGUE VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; SEQUENCE ALIGNMENT; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

DENGUE VIRUS; DENGUE VIRUS GROUP; DENGUE VIRUS TYPE 2; FLAVIVIRUS; MAMMALIA;

EID: 79953094417     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.01.030     Document Type: Article

References (40)

1. Beasley D.W., Aaskov J.G. Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies. Virology 2001, 279(2):447-458.
2. Brackney D.E., Foy B.D., Olson K.E. The effects of midgut serine proteases on dengue virus type 2 infectivity of Aedes aegypti. Am. J. Trop. Med. Hyg. 2008, 79(2):267-274.
3. Bray M., Men R., Tokimatsu I., Lai C.J. Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J. Virol. 1998, 72(2):1647-1651.
4. Bressanelli S., Stiasny K., Allison S.L., Stura E.A., Duquerroy S., Lescar J., Heinz F.X., Rey F.A. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 2004, 23(4):728-738.
5. Butrapet S., Kinney R.M., Huang C.Y. Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA. J. Virol. Meth. 2006, 131(1):1-9.
6. Cecilia D., Gould E.A. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis-virus neutralization-resistant mutants. Virology 1991, 181(1):70-77.
7. Chambers T.J., Nickells M. Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone. J. Virol. 2001, 75(22):10912-10922.
8. Chu J.J., Ng M.L. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J. Virol. 2004, 78(19):10543-10555.
9. Crill W.D., Chang G.J. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J. Virol. 2004, 78:13975-13986.
10. Duarte dos Santos C.N., Frenkiel M.P., Courageot M.P., Rocha C.F., Vazeille-Falcoz M.C., Wien M.W., Rey F.A., Deubel V., Despres P. Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus. Virology 2000, 274(2):292-308.
11. Erb S.M., Butrapet S., Moss K.J., Luy B.E., Childers T., Calvert A.E., Silengo S.J., Roehrig J.T., Huang C.Y.-H., Blair C.D. Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes. Virology 2010.
12. Gollins S.W., Porterfield J.S. Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry. J. Gen. Virol. 1985, 66(Pt 9):1969-1982.
13. Guirakhoo F., Hunt A.R., Lewis J.G., Roehrig J.T. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology 1993, 194(1):219-223.
14. Hasegawa H., Yoshida M., Shiosaka T., Fujita S., Kobayashi Y. Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology 1992, 191(1):158-165.
15. Heinz F.X. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 1986, 31:103-168.
16. Huang C.Y., Butrapet S., Moss K.J., Childers T., Erb S.M., Calvert A.E., Silengo S.J., Kinney R.M., Blair C.D., Roehrig J.T. The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion. Virology 2010, 396(2):305-315.
17. Hurrelbrink R.J., McMinn P.C. Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein. J. Virol. 2001, 75(16):7692-7702.
18. Kinney R.M., Butrapet S., Chang G.J., Tsuchiya K.R., Roehrig J.T., Bhamarapravati N., Gubler D.J. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 1997, 230:300-308.
19. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., Baker T.S., Strauss J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002, 108:717-725.
20. Lee E., Weir R.C., Dalgarno L. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein. Virology 1997, 232(2):281-290.
21. Mandl C.W., Guirakhoo F., Holzmann H., Heinz F.X., Kunz C. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J. Virol. 1989, 63(2):564-571.
22. McMinn P.C., Lee E., Hartley S., Roehrig J.T., Dalgarno L., Weir R.C. Murray valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice. Virology 1995, 211(1):10-20.
23. McMinn P.C., Marshall I.D., Dalgarno L. Neurovirulence and neuroinvasiveness of Murray Valley encephalitis virus mutants selected by passage in a monkey kidney cell line. J. Gen. Virol. 1995, 76(Pt 4):865-872.
24. Modis Y., Ogata S., Clements D., Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl Acad. Sci. USA 2003, 100(12):6986-6991.
25. Modis Y., Ogata S., Clements D., Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427(6972):313-319.
26. Modis Y., Ogata S., Clements D., Harrison S.C. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 2005, 79(2):1223-1231.
27. Monath T.P., Arroyo J., Levenbook I., Zhang Z.X., Catalan J., Draper K., Guirakhoo F. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J. Virol. 2002, 76(4):1932-1943.
28. Morita K., Tadano M., Nakaji S., Kosai K., Mathenge E.G., Pandey B.D., Hasebe F., Inoue S., Igarashi A. Locus of a virus neutralization epitope on the Japanese encephalitis virus envelope protein determined by use of long PCR-based region-specific random mutagenesis. Virology 2001, 287(2):417-426.
29. Mosso C., Galvan-Mendoza I.J., Ludert J.E., del Angel R.M. Endocytic pathway followed by dengue virus to infect the mosquito cell line C6/36 HT. Virology 2008, 378(1):193-199.
30. Ni H., Ryman K.D., Wang H., Saeed M.F., Hull R., Wood D., Minor P.D., Watowich S.J., Barrett A.D.T. Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants. J. Virol. 2000, 74(6):2903-2906.
31. Rey F.A., Heinz F.X., Mandl C., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature 1995, 375(6529):291-298.
32. Roehrig J.T., Bolin R.A., Kelly R.G. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 1998, 246(2):317-328.
33. Roehrig J.T., Johnson A.J., Hunt A.R., Bolin R.A., Chu M.C. Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology 1990, 177(2):668-675.
34. Schlesinger J.J., Chapman S., Nestorowicz A., Rice C.M., Ginocchio T.E., Chambers T.J. Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain. J. Gen. Virol. 1996, 77(Pt 6):1277-1285.
35. Stiasny K., Bressanelli S., Lepault J., Rey F.A., Heinz F.X. Characterization of a membrane-associated trimeric low-pH-induced Form of the class II viral fusion protein E from tick-borne encephalitis virus and its crystallization. J. Virol. 2004, 78(6):3178-3183.
36. Stiasny K., Kossl C., Lepault J., Rey F.A., Heinz F.X. Characterization of a structural intermediate of flavivirus membrane fusion. PLoS Pathog. 2007, 3(2):e20.
37. van der Schaar H.M., Rust M.J., Chen C., van der Ende-Metselaar H., Wilschut J., Zhuang X., Smit J.M. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 2008, 4(12):e1000244.
38. Wang E., Ryman K.D., Jennings A.D., Wood D.J., Taffs F., Minor P.D., Sanders P.G., Barrett A.D.T. Comparison of genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine. J. Gen. Virol. 1995, 76:2749-2755.
39. Zhang W., Chipman P.R., Corver J., Johnson P.R., Zhang Y., Mukhopadhyay S., Baker T.S., Strauss J.H., Rossmann M.G., Kuhn R.J. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat. Struct. Biol. 2003, 10(11):907-912.
40. Zhang Y., Zhang W., Ogata S., Clements D., Strauss J.H., Baker T.S., Kuhn R.J., Rossmann M.G. Conformational changes of the flavivirus E glycoprotein. Structure 2004, 12(9):1607-1618.